blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3059337

EP3059337 - ADAPTIVE IMMUNITY PROFILING AND METHODS FOR GENERATION OF MONOCLONAL ANTIBODIES [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  31.05.2023
Database last updated on 03.04.2025
FormerThe patent has been granted
Status updated on  29.03.2019
FormerGrant of patent is intended
Status updated on  22.11.2018
FormerExamination is in progress
Status updated on  13.10.2017
Most recent event   Tooltip02.06.2023Revocation of patentpublished on 05.07.2023  [2023/27]
Applicant(s)For all designated states
Adaptive Biotechnologies Corporation
1551 Eastlake Avenue East
Suite 200
Seattle, Washington 98102 / US
[2016/34]
Inventor(s)01 / WILEY, Steven, R.
c/o Adaptive Biotechnologies Corporation
1551 Eastlake Avenue East
Suite 200
Seattle, WA 98102 / US
 [2016/41]
Representative(s)Boult Wade Tennant LLP
Salisbury Square House
8 Salisbury Square
London EC4Y 8AP / GB
[N/P]
Former [2019/18]Boult Wade Tennant LLP
5th Floor, Salisbury Square House
8, Salisbury Square
London EC4Y 8AP / GB
Former [2016/34]Boult Wade Tennant
Verulam Gardens
70 Gray's Inn Road
London WC1X 8BT / GB
Application number, filing date16162568.615.01.2010
[2016/34]
Priority number, dateUS20090145039P15.01.2009         Original published format: US 145039 P
[2016/34]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3059337
Date:24.08.2016
Language:EN
[2016/34]
Type: B1 Patent specification 
No.:EP3059337
Date:01.05.2019
Language:EN
[2019/18]
Search report(s)(Supplementary) European search report - dispatched on:EP20.07.2016
ClassificationIPC:C40B50/06, C12N5/078, C12Q1/68
[2016/34]
CPC:
C07K16/205 (EP,US); C12Q1/6874 (US); C12N15/1034 (EP,US);
C40B50/06 (EP,US); C12N15/1072 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2016/34]
TitleGerman:ADAPTIVE IMMUNITÄTSPROFILIERUNG UND VERFAHREN ZUR ERZEUGUNG MONOKLONALER ANTIKÖRPER[2016/34]
English:ADAPTIVE IMMUNITY PROFILING AND METHODS FOR GENERATION OF MONOCLONAL ANTIBODIES[2016/34]
French:PROFILAGE D'IMMUNITÉ ADAPTATIVE ET PROCÉDÉS DE GÉNÉRATION D'ANTICORPS MONOCLONAUX[2016/34]
Examination procedure29.03.2016Examination requested  [2016/34]
24.02.2017Amendment by applicant (claims and/or description)
17.10.2017Despatch of a communication from the examining division (Time limit: M08)
15.06.2018Reply to a communication from the examining division
26.07.2018Despatch of a communication from the examining division (Time limit: M04)
03.10.2018Reply to a communication from the examining division
23.11.2018Communication of intention to grant the patent
21.03.2019Fee for grant paid
21.03.2019Fee for publishing/printing paid
21.03.2019Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP10732172.1  / EP2387627
Opposition(s)Opponent(s)01  31.01.2020  04.02.2020  ADMISSIBLE
Ablynx N.V.
Technologiepark 21
9052 Zwijnaarde / BE
Opponent's representative
Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
 [2020/11]
deletedDeletion: Legal effect of rejection of opposition [ N /P ]
20.02.2020Invitation to proprietor to file observations on the notice of opposition
01.09.2020Reply of patent proprietor to notice(s) of opposition
09.11.2021Date of oral proceedings
27.01.2022Despatch of minutes of oral proceedings
27.01.2022Date of despatch of rejection of opposition
17.05.2023Legal effect of revocation of patent [2023/27]
26.05.2023Despatch of communication that the patent will be revoked
Appeal following opposition28.03.2022Appeal received No.  T0836/22
28.03.2022Payment of appeal fee
03.06.2022Statement of grounds filed
17.05.2023Result of appeal procedure: revocation of the patent
26.05.2023Despatch of the decision of the Board of Appeal
16.05.2023Date of oral proceedings
23.05.2023Minutes of the oral proceedings despatched
Fees paidRenewal fee
29.03.2016Renewal fee patent year 03
29.03.2016Renewal fee patent year 04
29.03.2016Renewal fee patent year 05
29.03.2016Renewal fee patent year 06
29.03.2016Renewal fee patent year 07
27.01.2017Renewal fee patent year 08
29.01.2018Renewal fee patent year 09
28.01.2019Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU15.01.2010
AT01.05.2019
CY01.05.2019
CZ01.05.2019
EE01.05.2019
FI01.05.2019
HR01.05.2019
LT01.05.2019
LV01.05.2019
MC01.05.2019
MK01.05.2019
MT01.05.2019
PL01.05.2019
RO01.05.2019
SI01.05.2019
SK01.05.2019
SM01.05.2019
TR01.05.2019
BG01.08.2019
GR02.08.2019
IS01.09.2019
PT01.09.2019
LU15.01.2020
BE31.01.2020
[2022/32]
Former [2022/28]HU15.01.2010
AT01.05.2019
CY01.05.2019
CZ01.05.2019
EE01.05.2019
FI01.05.2019
HR01.05.2019
LT01.05.2019
LV01.05.2019
MC01.05.2019
MT01.05.2019
PL01.05.2019
RO01.05.2019
SI01.05.2019
SK01.05.2019
SM01.05.2019
TR01.05.2019
BG01.08.2019
GR02.08.2019
IS01.09.2019
PT01.09.2019
LU15.01.2020
BE31.01.2020
Former [2020/51]AT01.05.2019
CZ01.05.2019
EE01.05.2019
FI01.05.2019
HR01.05.2019
LT01.05.2019
LV01.05.2019
MC01.05.2019
PL01.05.2019
RO01.05.2019
SI01.05.2019
SK01.05.2019
SM01.05.2019
TR01.05.2019
BG01.08.2019
GR02.08.2019
IS01.09.2019
PT01.09.2019
LU15.01.2020
BE31.01.2020
Former [2020/46]AT01.05.2019
CZ01.05.2019
EE01.05.2019
FI01.05.2019
HR01.05.2019
LT01.05.2019
LV01.05.2019
MC01.05.2019
PL01.05.2019
RO01.05.2019
SI01.05.2019
SK01.05.2019
SM01.05.2019
TR01.05.2019
BG01.08.2019
GR02.08.2019
IS01.09.2019
PT01.09.2019
LU15.01.2020
Former [2020/39]AT01.05.2019
CZ01.05.2019
EE01.05.2019
FI01.05.2019
HR01.05.2019
LT01.05.2019
LV01.05.2019
MC01.05.2019
PL01.05.2019
RO01.05.2019
SI01.05.2019
SK01.05.2019
SM01.05.2019
TR01.05.2019
BG01.08.2019
GR02.08.2019
IS01.09.2019
PT01.09.2019
Former [2020/25]AT01.05.2019
CZ01.05.2019
EE01.05.2019
FI01.05.2019
HR01.05.2019
LT01.05.2019
LV01.05.2019
PL01.05.2019
RO01.05.2019
SI01.05.2019
SK01.05.2019
SM01.05.2019
TR01.05.2019
BG01.08.2019
GR02.08.2019
IS01.09.2019
PT01.09.2019
Former [2020/17]AT01.05.2019
CZ01.05.2019
EE01.05.2019
FI01.05.2019
HR01.05.2019
LT01.05.2019
LV01.05.2019
RO01.05.2019
SK01.05.2019
SM01.05.2019
TR01.05.2019
BG01.08.2019
GR02.08.2019
IS01.09.2019
PT01.09.2019
Former [2020/14]AT01.05.2019
CZ01.05.2019
EE01.05.2019
FI01.05.2019
HR01.05.2019
LT01.05.2019
LV01.05.2019
RO01.05.2019
SK01.05.2019
SM01.05.2019
BG01.08.2019
GR02.08.2019
IS01.09.2019
PT01.09.2019
Former [2020/11]AT01.05.2019
CZ01.05.2019
EE01.05.2019
FI01.05.2019
HR01.05.2019
LT01.05.2019
LV01.05.2019
RO01.05.2019
SK01.05.2019
BG01.08.2019
GR02.08.2019
IS01.09.2019
PT01.09.2019
Former [2020/10]AT01.05.2019
CZ01.05.2019
FI01.05.2019
HR01.05.2019
LT01.05.2019
LV01.05.2019
RO01.05.2019
BG01.08.2019
GR02.08.2019
IS01.09.2019
PT01.09.2019
Former [2020/09]CZ01.05.2019
FI01.05.2019
HR01.05.2019
LT01.05.2019
LV01.05.2019
BG01.08.2019
GR02.08.2019
IS01.09.2019
PT01.09.2019
Former [2020/04]FI01.05.2019
HR01.05.2019
LT01.05.2019
LV01.05.2019
BG01.08.2019
GR02.08.2019
IS01.09.2019
PT01.09.2019
Former [2019/51]FI01.05.2019
HR01.05.2019
LT01.05.2019
LV01.05.2019
BG01.08.2019
GR02.08.2019
PT01.09.2019
Former [2019/50]FI01.05.2019
HR01.05.2019
LT01.05.2019
LV01.05.2019
GR02.08.2019
PT01.09.2019
Former [2019/48]FI01.05.2019
LT01.05.2019
PT01.09.2019
Former [2019/47]FI01.05.2019
LT01.05.2019
Documents cited:Search[XPI]EP2088432  (MORPHOSYS AG [DE]) [XP] 1,2,5-8,11-13 * paragraphs [0011] , [0012] , [0021] , [0022] , [0035] , [0037] , [0041]; claims 1-17 *[I] 3,4,9,10,14,15
by applicantUS4342566
 US4458066
 US4683195
 US4683202
 US4816567
 US5225539
 US5426039
 US5449614
 US5474935
 US5580859
 US5585089
 US5631236
 US5658775
 US5714330
 US5721118
 US5846719
 US6013445
 US6025155
 WO0018957
 WO0037504
 US6096718
 US6107478
 US6110458
 US6110456
 US6113913
 US6117681
 WO0114424
 US2004126829
    - WARD ET AL., NATURE, (1989), vol. 341, pages 544 - 546
    - BIRD ET AL., SCIENCE, (1988), vol. 242, pages 423 - 426
    - HUSTON ET AL., PROC NATL ACAD SCI USA, (1988), vol. 85, pages 5879 - 5883
    - QUEEN ET AL., PROC NATL ACAD SCI USA, (1989), vol. 86, pages 10029 - 10033
    - WINDHAGEN ET AL., IMMUNITY, (1995), vol. 2, pages 373 - 380
    - HARDING ET AL., PROC NATL ACAD SCI, (1989), vol. 86, pages 4230 - 4234
    - SIRAGANIAN ET AL., TIPS, (1983), vol. 4, pages 432 - 437
    - PETERS ET AL., BLOOD, (1988), vol. 72, pages 1310 - 1315
    - MORRISON ET AL., PROC NATL ACAD SCI, (1984), vol. 81, pages 6851 - 6855
    - ELLOUZ ET AL., BIOCHEM BIOPHYS RES COMMUN, (1974), vol. 59, page 1317
    - CHEDID ET AL., PROG ALLERGY, (1978), vol. 25, page 63
    - BYARS ET AL., VACCINE, (1987), vol. 5, page 223
    - CHEDID ET AL., INFECT IMMUN, vol. 35, page 417
    - GISLER ET AL., IMMUNOMODULATIONS OF MICROBIAL PRODUCTS AND RELATED SYNTHETIC COMPOUNDS, (1981), vol. 167
    - OTT ET AL., "MF59--Design and Evaluation of a Safe and Potent Adjuvant for Human Vaccines", VACCINE DESIGN: THE SUBUNIT AND ADJUVANT APPROACH, (1995), pages 277 - 296
    - WHITE ET AL., ADV EXP MED BIOL, (1991), vol. 303, pages 207 - 210
    - KENSIL ET AL., J IMMUNOL, (1992), vol. 148, pages 1519 - 1525
    - KENSIL ET AL., J IMMUNOL, (1991), vol. 146, pages 431 - 437
    - CHOMCZYNSKI; SACCHI, ANAL BIOCHEM, (1987), vol. 162, pages 156 - 159
    - WU, GENOMICS, (1989), vol. 4, page 560
    - LANDEGREN, SCIENCE, (1988), vol. 241, page 1077
    - KWOH, PROC NATL ACAD SCI USA, (1989), vol. 86, page 1173
    - GUATELLI, PROC NATL ACAD SCI USA, (1990), vol. 87, page 1874
    - SMITH, J CLIN MICROBIOL, (1997), vol. 35, pages 1477 - 1491
    - BURG, MOL CELL PROBES, (1996), vol. 10, pages 257 - 271
    - BERGER, METHODS ENZYMOL, (1987), vol. 152, pages 307 - 316
    - SOOKNANAN, BIOTECHNOLOGY, (1995), vol. 13, pages 563 - 564
    - ADESSI ET AL., NUCLEIC ACIDS RES, (2000), vol. 28, no. 20, page E87
    - SHENDURE ET AL., "Accurate Multiplex Polony Sequencing of an Evolved Bacterial Genome", SCIENCEXPRESS, (20050804), page 1
    - ADAMS, J AM CHEM SOC, (1983), vol. 105, page 661
    - BELOUSOV, NUCLEIC ACIDS RES, (1997), vol. 25, pages 3440 - 3444
    - FRENKEL, FREE RADIC BIOL MED, (1995), vol. 19, pages 373 - 380
    - BLOMMERS, BIOCHEMISTRY, (1994), vol. 33, pages 7886 - 7896
    - NARANG, METH ENZYMOL, (1979), vol. 68, page 90
    - BROWN, METH ENZYMOL, (1979), vol. 68, page 109
    - BEAUCAGE, TETRA LETT, (1981), vol. 22, page 1859
    - SAMBROOK AND RUSSELL,, MOLECULAR CLONING: A LABORATORY MANUAL (3rd ED.),, COLD SPRING HARBOR LABORATORY, (2001), vol. 1-3
    - ROSENFELD, NAT GENET, (1997), vol. 15, pages 333 - 335
    - WOON, GENOMICS, (1998), vol. 50, pages 306 - 316
    - KERN, BIOTECHNIQUES, (1997), vol. 23, pages 120 - 124
    - WILLIAMS, BIOCHEMISTRY, (1995), vol. 34, pages 1787 - 1797
    - DOBELI, PROTEIN EXPR PURIF, (1998), vol. 12, pages 404 - 414
    - KROLL, DNA CELL BIOL, (1993), vol. 12, pages 441 - 53
    - KABAT ET AL., Sequences of Proteins of Immunological Interest, 5th ed.,, NIH PUBL., (1991), pages 91 - 3242
    - ROBERTS, NATURE, (1987), vol. 328, page 731
    - SCHNEIDER, PROTEIN EXPR PURIF, (1995), vol. 10, page 6435
    - FENG, NATURE BIOTECHNOLOGY, (1997), vol. 15, pages 866 - 870
    - BUCHSCHER, J VIROL, (1992), vol. 66, pages 2731 - 2739
    - JOHANN, J VIROL, (1992), vol. 66, pages 1635 - 1640
    - OKADA, GENE THER, (1996), vol. 3, pages 957 - 964
    - CUMBER ET AL., METHODS OF ENZYMOLOGY, (1985), vol. 112, pages 207 - 224
    - NEISES ET AL., ANGEW CHEM, INT ED ENGL, (1978), vol. 17, page 522
    - HASSNER ET AL., TETRAHEDRON LETT, (1978), page 4475
    - BODEN ET AL., J ORG CHEM, (1986), vol. 50, page 2394
    - MATHIAS, SYNTHESIS, (1979), page 561
    - BEATTY ET AL., J IMM METH, (1987), vol. 100, pages 173 - 179
OppositionUS6013445
 US2006233812
 EP2088432
    - KOUMI, PIERIS et al., "Evaluation and validation of the ABI 3700, ABI 3100, and the MegaBACE 1000 capillary array electrophoresis instruments for use with short tandem repeat microsatellite typing in a forensic environment.", Electrophoresis, (20040000), pages 2227 - 2241, XP055680270

DOI:   http://dx.doi.org/10.1002/elps.200305976
    - SCHUSTER, STEPHAN C, "Next-generation sequencing transforms today's biology", Nature Methods, (20080000), pages 16 - 18, XP008106842

DOI:   http://dx.doi.org/10.1038/NMETH1156
    - JANITZ, et al., "4 The Next-Generation Genome Sequencing 454/Roche GS FLX", Next-Generation Genome Sequencing Towards Personalized Medicine, (20080000), pages 43 - 56, XP055680274

DOI:   http://dx.doi.org/10.1002/9783527625130.ch4
    - MARDIS, ELAINE R., "The impact of next-generation sequencing technology on genetics", TRENDS IN GENETICS, (20080000), pages 133 - 141, XP022498431
    - MARDIS, ELAINE R., "Next-generation DNA sequencing methods", ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, (20080000), pages 387 - 402, XP002512993

DOI:   http://dx.doi.org/10.1146/ANNUREV.GENOM.9.081307.164359
    - SHENDURE, JAY et al., "Advanced sequencing technologies: methods and goals", NATURE REVIEWS GENETICS, (20040000), pages 335 - 344, XP002341058

DOI:   http://dx.doi.org/10.1038/nrg1325
    - REINARTZ, JEANNETTE et al., "Massively parallel signature sequencing (MPSS) as a tool for in-depth quantitative gene expression profiling in all organism", BRIEFING IN FUNCTIONAL GENOMICS & PROTEOMICS, (20020000), pages 95 - 104, XP008148437

DOI:   http://dx.doi.org/10.1093/bfgp/1.1.95
    - HALL, NEIL, "Advanced sequencing technologies and their wider impact in microbiology", Journal of Experimental Biology, (20070000), pages 1518 - 1525, XP055167237

DOI:   http://dx.doi.org/10.1242/jeb.001370
    - SEMPLE, JOHN W. et al., "Rapid separation of CD4+ and CD19+ lymphocyte populations from human peripheral blood by a magnetic activated cell sorter (MACS)", CYTOMETRY, (19930000), pages 955 - 960, XP055680279

DOI:   http://dx.doi.org/10.1002/cyto.990140816
    - JANEWAY, CHARLES et al., "Applications and Optimization of Immunization Procedures", Janeway's immuno biology, (20080000), pages 241 - 257, XP055680282

DOI:   http://dx.doi.org/10.1093/ilar.46.3.241
    - SCHUNK, MICHAEL K et al., "Applications and Optimization of Immunization Procedures", ILAR JOURNAL, (20050000), pages 241 - 257, XP055680282

DOI:   http://dx.doi.org/10.1093/ilar.46.3.241
    - LAMBERT, PAUL-HENRI et al., "Can successful vaccines teach us how to induce efficient protective immune responses?", Nature Medicine, (20050000), pages S54 - S62, XP055325169

DOI:   http://dx.doi.org/10.1038/nm1216
    - YAMASHITA, M. et al., "Recent advances in the generation of human monoclonal antibody", Cytotechnology, (20070000), pages 241 - 257, XP019550372

DOI:   http://dx.doi.org/10.1007/s10616-007-9072-5
    - Henny R Hoogenboom, "Overview of Antibody Phage-Display Technology and Its Applications", Methods in Molecular Biology, (2002), pages 1 - 37, XP009065679

DOI:   http://dx.doi.org/10.1385/1-59259-240-6:001
    - LI, WEIZHONG et al., "Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences", BIOINFORMATICS, (20060000), pages 1658 - 1659, XP055373400

DOI:   http://dx.doi.org/10.1093/bioinformatics/btl158
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.